Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:1049-1053

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yao, L. P.
Right arrow Articles by Jose, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yao, L. P.
Right arrow Articles by Jose, P. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1998;32:1049-1053.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Dopamine D1 Receptor and Protein Kinase C Isoforms in Spontaneously Hypertensive Rats

Lynne P. Yao; Xiao Xi Li; Pei-Ying Yu; Jing Xu; Laureano D. Asico; Pedro A. Jose

From the Walter Reed Army Medical Centers (L.P.Y.) and Georgetown University Medical Center, Washington, DC.

Correspondence to Dr Pedro A. Jose, Georgetown University Medical Center 2-PHC, 3800 Reservoir Rd NW, Washington, DC 20007. E-mail josep{at}gunet.georgetown.edu

Abstract—Dopamine, via D1-like receptors, stimulates the activity of both protein kinase A (PKA) and protein kinase C (PKC), which results in inhibition of renal sodium transport. Since D1-like receptors differentially regulate sodium transport in normotensive and hypertensive rats, they may also differentially regulate PKC expression in these rat strains. Thus, 2 different D1-like agonists (fenoldopam or SKF 38393) were infused into the renal artery of anesthetized normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) (n=5 to 6/drug/strain). Ten or 60 minutes after starting the D1-like agonist infusion, both the infused kidney and the noninfused kidney that served as control were prepared for analysis. The D1-like agonists produced a greater diuresis and natriuresis and inhibited Na+,K+-ATPase activity in proximal tubule (PT) and medullary thick ascending limb (mTAL) to a greater extent in WKY ({Delta}20±1%) than in SHR ({Delta}7±1%, P<0.001). D1-like agonists had no effect on PKC-{alpha} or PKC-{lambda} expression in either membrane or cytosol but increased PKC-{theta} expression in PT in both WKY and SHR at 10 minutes but not at 60 minutes. However, membranous PKC-{delta} expression in PT and mTAL decreased in WKY but increased in SHR with either 10 or 60 minutes of D1-like agonist infusion. D1-like agonists also decreased membranous PKC-{zeta} expression in PT and mTAL in WKY but increased it in PT but not in mTAL in SHR. We conclude that there is differential regulation of PKC isoform expression by D1-like agonists that inhibits membranous PKC-{delta} and PKC-{zeta} in WKY but stimulates them in SHR; this effect in SHR is similar to the stimulatory effect of norepinephrine and angiotensin II and may be a mechanism for their differential effects on sodium transport.


Key Words: receptors, dopamine • kidney tubules, proximal • renal medulla • protein kinase C




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Escano, I. Armando, X. Wang, L. D. Asico, A. Pascua, Y. Yang, Z. Wang, Y.-S. Lau, and P. A. Jose
Renal dopaminergic defect in C57Bl/6J mice
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2009; 297(6): R1660 - R1669.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Li, C. Yu, Y. Han, H. Ren, W. Shi, C. Fu, D. He, L. Huang, C. Yang, X. Wang, et al.
Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2761 - H2768.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose
Functional genomics of the dopaminergic system in hypertension
Physiol Genomics, November 17, 2004; 19(3): 233 - 246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Asghar, T. Hussain, and M. F. Lokhandwala
Overexpression of PKC-{beta}I and -{delta} contributes to higher PKC activity in the proximal tubules of old Fischer 344 rats
Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1100 - F1107.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Chen, C. Wersinger, and A. Sidhu
Chronic Stimulation of D1 Dopamine Receptors in Human SK-N-MC Neuroblastoma Cells Induces Nitric-oxide Synthase Activation and Cytotoxicity
J. Biol. Chem., July 18, 2003; 278(30): 28089 - 28100.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
T. Hussain and M. F. Lokhandwala
Renal Dopamine Receptors and Hypertension
Experimental Biology and Medicine, February 1, 2003; 228(2): 134 - 142.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Li, C. L. Chik, A. K. Ho, and E. Karpinski
L-Type Ca2+ Channel Regulation by Pituitary Adenylate Cyclase-Activating Polypeptide in Vascular Myocytes from Spontaneously Hypertensive Rats
Endocrinology, July 1, 2001; 142(7): 2865 - 2873.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. ASGHAR, V. KANSRA, T. HUSSAIN, and M. F. LOKHANDWALA
Hyperphosphorylation of Na-Pump Contributes to Defective Renal Dopamine Response in Old Rats
J. Am. Soc. Nephrol., February 1, 2001; 12(2): 226 - 232.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
E. Feraille and A. Doucet
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Physiol Rev, January 1, 2001; 81(1): 345 - 418.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Nowicki, M. S. Kruse, H. Brismar, and A. Aperia
Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells
Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1812 - C1818.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Yu, L. D. Asico, G. M. Eisner, U. Hopfer, R. A. Felder, and P. A. Jose
Renal Protein Phosphatase 2A Activity and Spontaneous Hypertension in Rats
Hypertension, December 1, 2000; 36(6): 1053 - 1058.
[Abstract] [Full Text] [PDF]